Skip to content

Comparison of 1 Versus 2 Days Post-Operative Catheterization After Anterior Colporrhaphy

Comparison of 1 Versus 2 Days Post-Operative Catheterization After Anterior Colporrhaphy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06429228
Enrollment
100
Registered
2024-05-24
Start date
2020-04-20
Completion date
2025-01-01
Last updated
2025-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anterior Vaginal Wall Prolapse, Catheter Related Complication

Brief summary

Patients who undergo anterior vaginal wall plastic surgery and place the bladder catheter during surgery are selected. The purpose of the study is to evaluate the presence of statistically significant differences in bladder catheter repositioning within 12 hours after bladder catheter removal in the group of patients in whom the bladder catheter is removed on postoperative day I or II. Secondary outcomes include evaluation of the incidence of urinary tract infections, number of hospitalization days and total hospitalization costs for patients undergoing anterior vaginal wall surgery in patients in whom the bladder catheter is removed on postoperative day I or II.

Interventions

PROCEDURECatheter removal after surgery

Removal of catheter placed during the procedure in first or second post-surgical days.

Sponsors

IRCCS San Raffaele
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Women 18 years of age or older * Patients who are candidates for cystopexy surgery * Patients who have consented to the signing of the Informed Consent

Exclusion criteria

* Micturition dysfunction with preoperative bladder stagnation \> 200 cc at pessary evaluation * History of recurrent cystitis * Positive preoperative urine culture * Azotemia \> 40 mg/dL or creatininemia \> 1 mg/dL * Not collected signed consent endorsed * Diabetes mellitus * Contraindications to transurethral bladder catheterization * Major protocol violations due to unforeseen intraoperative complications (bladder and/or rectal damage, severe bleeding with need for urinary monitoring)

Design outcomes

Primary

MeasureTime frameDescription
differences in bladder catheter repositioning within 12 hours after bladder catheter removal12 hoursAfter removal of the bladder catheter, on postoperative day I or II, the appearance of urinary urge will be assessed and, in case of spontaneous urination, the quantity of urine will be measured. In the event that after the waiting time of 6 hours an adequate urination stimulus does not arise, we will proceed with an ultrasound evaluation of bladder stagnation (RV) and the application of the department protocol, as follows: * if the sum of diuresis and RV is between 500 and 1000 cc, extemporaneous catheterization and re-evaluation after 4 hours are indicated * if the sum of diuresis and RV is \> 1000cc, positioning of a bladder catheter and maintenance of the same for 5-7 days with subsequent evaluation is indicated.

Secondary

MeasureTime frameDescription
incidence of urinary tract infections for patients undergoing cystopexy surgery in patients in whom the bladder catheter is removed on postoperative day I or II.During hospital stayBefore removing the catheter, a chemical-physical examination will be carried out; if this is positive, urine culture will be carried out. The diagnosis of urinary tract infection will be made with leukocyturia greater than 25 cells per field, positivity for urinary nitrite, presence of at least 20 bacteria per field, bacteriuria and/or more than 100,000 colony forming units associated with at least one of the following signs (fever, dysuria, increased urinary frequency, suprapubic pain, burning on urination or worsening of urinary incontinence). Patients with a positive culture and/or who show symptoms attributable to urinary tract infection will be subjected to antibiotic therapy.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026